The Internaional Myeloma Working Group forges the path to precision myeloma care

Each patient with multiple myeloma is different. Within a myeloma support group, one can learn a lot about testing and treatments, but outcomes for individual patients are often very different. These differences must be studied in rigorously designed clinical trials to double-check test results and treatment details. So, while it might be tempting to compare what happened with Joe or Mary to yourself, the best guidance for your individual treatment is based on the best myeloma research, clinical trials, consensus statements, and guidelines. 

Bold Initiative Comes to Fruition: First Asian Myeloma Network Summit

This past weekend (October 13-15), the International Myeloma Foundation convened the first Asian Myeloma Network (AMN) Summit in Seoul, Korea. The seven countries/regions that make up the AMN – China, Hong Kong, Taiwan, Japan, Korea, Singapore, and Thailand – have worked collaboratively under the auspices of the IMF since 2011. With its structure modeled on the annual International Myeloma Working Group (IMWG) Summit, the Seoul meeting addressed a broad range of issues, examining the status in Asia of myeloma diagnosis, research, and treatment, as well as the next steps in implementing data-gathering and clinical trials in the region.  AMN members are clearly excited to be able to measure up to top US and European research groups, such as SWOG, ECOG, IFM, EMN, and the like. Expansion of myeloma research anywhere in the world has the potential to benefit myeloma patients everywhere.

University of California girds to combat cancer, a closer look at CAR-T cell therapy, and medical tourism to China—a wave of the future?

With new drug approvals and expanded indications for new myeloma drugs at an all-time high, there is a sense of optimism in the myeloma community. Yet, even as patients experience longer survival, myeloma remains very sneaky. The disease can evolve into resistant relapse phases, demanding new therapy.

Global Myeloma Voices Come Together to Drive Research and Improve Lives of Patients

Madrid BlogThis past week was very busy and important for the global myeloma community, which is increasingly coming together with a single voice for myeloma research and patient care. In Madrid, Spain, on the eve of the 2017 Congress of the European Hematology Association, the IMF provided platforms for many of these global research voices at the 2017 International Myeloma Working Group® (IMWG) Summit, as well as during the regular research update meeting of the IMF Black Swan Research Initiative® investigators team.

PET/CT Scanning Comes of Age: New IMWG Guidelines Published

New IMWG guidelines for PET/CT scanning have been published inThe Lancet Oncology. In his blog this week, IMF Chairman Dr. Brian Durie congratulates Dr. Michele Cavo and his team for their report on this extremely accurate imaging technique, used to establish a diagnosis and to monitor throughout the course of the disease. “The new IMWG guidelines provide a comprehensive review of the current role and optimal uses of FDG PET/ CT scanning,” he writes.

Pages